Conditions of the gastrointestinal system, the liver and the pancreas affect 70 million or more Americans. These conditions can be difficult to identify, and some are resistant to effective treatments.
Digestive diseases are not only quality-of-life inhibitors, but they can also be potentially deadly. Cancers in the gastrointestinal system carry high mortality rates. Colorectal cancer is the third-leading cause of cancer death, and pancreatic cancer kills more than 30,000 Americans each year — nearly the same number as those diagnosed.
Dedicated research is needed to better understand the way these conditions function and what role patients' genetics and environments play in how they develop.
Mayo Clinic is home to the world's preeminent experts in digestive diseases, both in our clinical practice and in our research and education programs. With more than 140 specialists working in 13 subspecialty groups, Mayo is one of the largest digestive disease specialty practices in the world. We treat more than 90,000 patients each year.
We are also the world's leader in digestive disease research. Our research leverages the latest developments in the scientific understanding of diseases to bring new solutions to patients with gastrointestinal conditions.
Mayo Clinic's culture of collaboration across specialties ensures that we harness developments in individualized medicine, regenerative medicine and emerging areas to bring the best available science to gastrointestinal research and treatment improvements.
Mayo Clinic maintains major research programs in gastrointestinal conditions at the basic, applied and translational levels to make positive changes in the way we diagnose and treat disease. We are pursuing lines of research that will ease the suffering of patients with these conditions and ultimately address the underlying causes of their disease.
This research depends on our ability to develop a rich biorepository of diverse patient data. Because of our high-volume clinical practice and the rare and complex cases we treat, Mayo Clinic is uniquely qualified to lead the development of these resources. This biological data will support a wide range of gastrointestinal research that will lead to safe, effective treatment and diagnosis improvements.
Mayo Clinic is also committed to recruiting and training the next generation of physicians and scientists to lead the development of our field.
Philanthropic gifts accelerate the discovery, development and delivery of care that inspires optimism in people who need it most. Benefactors have an important role to play in advancing new treatments for gastrointestinal conditions. Our supporters can provide scholarships and career development awards for our researchers; help us build our biorepository resources; and protect time for our clinicians. Give today.
April 20, 2018